Article
MicroRNAs and depression.
Neurobiology of disease - 1 May 2012
Mouillet-Richard Sophie, Baudry Anne, Launay Jean-Marie, Kellermann Odile
Abstract excerpt
With an estimated life-time prevalence of 15 to 17% and an incapacitating illness in 50% of cases, depressive spectrum disorders represent a heavy public health burden. Despite considerable efforts to underpin the molecular and cellular changes associated with depressive states, a global understanding of the pathophysiology of major depressive disorders (MDD) is still lacking. It is now acknowledged that deficits...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
